Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking cessation during radiotherapy for head and neck cancer
ACTRN12614000876695Phase 4Terminated
- Sponsor
- Dr Benjamin Britton
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of varenicline in nicotine dependence and head and neck cancer (HNC) (2 arms), sponsored by Dr Benjamin Britton. Primary endpoint: Feasibility and acceptability. Started Oct 2014; status: terminated.
02
Drugs
varenicline
03
Conditions
nicotine dependencehead and neck cancer (HNC)
Beyond the preview
Go deeper on ACTRN12614000876695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000876695.